(Date:10/13/2008)... ANN ARBOR, Mich., Oct. 13 /PRNewswire/ -- Thomson... in Albany, NY, has significantly improved,its cor...charge instruction,compliance for heart failure pa...100 percent in first-quarter 2008., St. Peter,s H...of,Albany, is one of only 10 hospitals in the nati...
(Date:10/13/2008)... Integrated Project Manageme...f 15 companies nationwide named a “Top Small...inning Workplaces. Winners are profiled in today&r...ness ). IPM provides project management and consul...uding the life sciences, food and beverage, health...
(Date:10/13/2008)...affeine consumption does not appear to be associat... report in the October 13 issue of Archives of In...als. However, there is a possibility of increased ...umors that are hormone-receptor negative or larger...most commonly consumed drug worldwide, present in ...
(Date:10/13/2008)...isual impairment appears to be more common in peop..., according to a report in the October issue of A...es journals. , Approximately 14.6 million Amer...another 6.2 million had undiagnosed diabetes, acco... is estimated that the number of individuals with ...
Breaking Medicine News(10 mins):Health News:St. Peter's Hospital of Albany Improves Core Measures Processes 2Health News:St. Peter's Hospital of Albany Improves Core Measures Processes 3Health News: Integrated Project Management Named a "Top Small Workplace" by The Wall Street Journal and Winning Workplaces 2Health News: Integrated Project Management Named a "Top Small Workplace" by The Wall Street Journal and Winning Workplaces 3Health News:Study examines association between caffeine consumption and breast cancer risk 2Health News:Vision loss more common in people with diabetes 2...ascular surgeon at London's Middlesex Hospital, ad...there is nothing to fear. The death of a woman on ...tance flight, has sparked off this sudden debate t...o many people. Dr. Scurr says this fear is unfound...
...opausal women suffer from sexual dysfunctions- pai...titude of physiological and psychological problems...icated better, most of these problems can be treat...o through menopause, will gradually develop change...
...k with a vengeance. The killer disease of the past... a new partner in its destructive mission. Full-bl... average three million people a year in Africa alo...up by 10% in 2 years and there are no signs of the...
...early all deaths due to asthma can be prevented if...anding of the disease. According to WHO, around 15...nearly 2 lakh people die due to the disease every ...ten linked with allergies, that is characterized b...
Other Medicine News:(Date:10/10/2008)...EEK, Mich., Oct. 10 /- Diplomat Speci...ce has selected Diplomat,Specialty Pharmacy to be ...scale, national Therapy Optimization Study for Mul...ear TOP MS study, is to examine the benefits of a,...ompliance, adherence and,patient outcomes. Targete...
(Date:10/10/2008)...ass., Oct. 10 /- Boston Sci...the schedule of the Company,s major,events and pre...undation,s,(CRF) twentieth annual Transcatheter Ca...um, which runs from October 12 to 17 in Washington...de range of safety and,efficacy data on its TAXUS(...
(Date:10/9/2008)...ht Day 2008 focuses on the need to protect the eye...re/ -- Of the 45 million people worldwide who,are ...ers of them could,have avoided their blindness if ...view the Multimedia News Release, go to:, http://w...orld,s leader in eye care products and equipment, ...
(Date:10/9/2008)...ranslational Science Institute, Navigenics, Affyme...tudy, SAN DIEGO, Oct. 9 /- A consort...s have joined forces in a first-of-its-kind,resear...al genetic testing,on people who choose to receive...for developing certain diseases., Sponsored by Sc...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 1CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 2New Foam Treatment for Varicose Veins 14633 1New Foam Treatment for Varicose Veins 14633 2MultiVu Video Feed 3A Stinky Sneakers Worth Big Money 21 14630 1MultiVu Video Feed 3A Stinky Sneakers Worth Big Money 21 14630 2Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 1Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 2Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 3Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 4Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 5Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 6...4, 2007 - Researchers at,Molecular Insight Pharmac...inical data on MIP-1072, a radiolabeled, small mol...ent for diagnosis and,staging of prostate cancer a...r Medicine (SNM) in Washington, D.C. MIP-1072 is,o...er diagnosis,that Molecular Insight plans to advan...
...ewswire-FirstCall/ --,Bionovo, Inc.,s lead drug ca...r the treatment of hot flashes associated with men...led in the company,s,double-blind, placebo- contro...en with 50 or more moderate to severe hot flashes,... groups receiving,MF101 (5 grams/day), MF101 (10 g...
Other Medicine Technology:Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol
Triad Plus Sterile Skin Protectant Prep Pads prepares the skin for improved adhesion of a bandage or dressing. When dry, it leaves a thin film on the skin's surface. This provides a clean surface and
...opyl Alcohol 70% USP and 10% Acetone Alcoh...eptic, anti-infective prior to administering injec...al of oils and fats from the skin. They are gamma ...o contain a consistent amount of alcohol &acetone ...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product.
Medicine Products: